EVENT
Expert Workshops on Sex and Gender in Medicines Regulation and Medical Education 4th March 2015, 0900-1730.
Room TRE7701, 7th floor, Trèves Building, 74 Rue de Trèves. European Economic and Social Committee, Brussels
Research addressing Sex and Gender (S&G) in biomedical science and health research is a novel and highly promising field. The interaction of S&G related mechanisms leads to different manifestation of diseases in women and men, such as infarction, heart failure, diabetes, rheumatic disease.
The European Gender Medicine Project (EUGenMed) will produce an innovative roadmap for the implementation of S&G in biomedical, public health and clinical research and create a European Gender Health Network.
Part 1: Sex and Gender in Medicines Regulation:
Translating the evidence from S&G research into regulatory practice will lead to more targeted, effective opportunities for prevention, treatment and care. This workshop will examine how S&G consideration are integrated into Medicines Regulation and information.
Co-Chairs
Dr. Ingrid Klingmann, Chairwoman, European Forum for Good Clinical Practice (EFGCP)
Ms. Hildrun Sundseth, President, European Institute of Women’s Health (EIWH)
09.00-09.10 Welcome
Dr. Ingrid Klingmann, EFGCP, and Hildrun Sundseth, EIWH
09.10-09.20 Opening Address
Ms. Ingrid Kössler, Member of the European Economic and Social Committee (EESC)
09.20-09.40 Sex and Gender in EU Regulatory Practice
Dr. Kevin Blake, European Medicines Agency (EMA), UK
09.40-09.55 The case of CVD and Women
Prof. Dr. Marco Stramba-Badiale, Director, Department of Geriatrics & Cardiovascular
Medicine, IRCCS Istituto Auxologico Italiano, Italy
09.55-10.10 Ethics Committee Guidelines:Example from the Medical University of Vienna
Dr. Christiane Druml, Vice-Rector, Medical University of Vienna, Austria
10.10-10.30 Discussion
10.30 -11.00 COFFEE BREAK
11.00-11.20 Moving Forward: The New Clinical Trials Regulation
Ms. Maja Grzymkowska, Medicinal Products–Quality, Safety and Efficacy Unit, DG SANTE
11.20-11:40 Safe Use of Medicines during Pregnancy and Lactation
Dr. Lode Dewulf, Chief Patient Affairs Officer, UCB, Belgium
11.55-13.00 Towards a European S&G Roadmap
Co-Chairs Dr. Ingrid Klingmann, EFGCP, Ms. Hildrun Sundseth, EIWH
Eugenmed: The Research Evidence for Integrating Sex and Gender into Clinical Studies: Prof. Dr. Ineke Klinge, Univ. of Maastricht, Charité—Universitätsmedizin, Board Member EIWH, Nederlands.
Research Perspective: Ute Seeland: Charité—Universitätsmedizin, Berlin, Germany
Patient Perspective: Ms. Sophie Peresson, International Diabetes Federation
Health Professional Perspective: Dr. Katrín Fjeldsted, CPME (TBC)
13:00- 14:00 LUNCH
Part 2: Sex and Gender in Medical Education
The failure to acknowledge the impact of sex and gender differences will affect the quality of health care provision, precisely what good medical education seeks to prevent. There must be a commitment to mainstream an evidence-based gender perspective throughout medical curriculum,including in graduate, medical, nursing, rehabilitation, pharmacy, continuing medical education and continuing nursing education programmes. This workshop will examine how S&G consideration can be best integrated into medical education.
Co-Chairs
Dr. Katrín Fjeldsted, President, Standing Committee of European Doctors (CPME), Iceland
Dr. Petra Verdonk, VU University Medical Centre, the Netherlands
14.00-14.15 Welcome and Introduction
Ms. Peggy Maguire, Director General, European Institute of Women’s Health, Ireland
14.15-15.00 Panel Discussion A: Examples on How to Best Integrate Sex and Gender in Medical Education
Chair: Ms. Sinead Hewson, Managing Partner of The Dendrite Group and EIWH Board Member, the Netherlands
Dr. Petra Verdonk, VU University Medical Centre:
Making a gender difference. Challenges of sex and gender mainstreaming in medical education.
Prof. Dr. Margarethe Hochleitner, Medical University Innsbruck, Austria: Integrating sex and gender in different curricula at the Medical University Innsbruck
Dr. Ute Seeland, Institute of Gender Medicine, Charité—Universitätsmedizin, Germany: Extension of S&G knowledge in medical education–the concept of eGender
Ms. Sabine Ludwig, Charité—Universitätsmedizin, Germany: Curricular integration of sex and gender aspects into the new modular medical curriculum at Charité Berlin
15.00-15.20 COFFEE BREAK
15.20-16.40 Panel Discussion B: Moving Forward—What are the Opportunities to Integrate Sex and Gender in Medical Education?
Chair: Prof. Karen Ritchie, Imperial College London, Director INSERM, Neuropsychiatrie Hôpital La Colombière and EIWH Board Member, France
Prof. Dr. Hanneke de Haes, Department of Medical Psychology, AMC-UvA, Netherlands: How communication was successfully integrated into Medical Education—can we use the same strategy for integrating sex and gender?
Ms. Kristina Mickeviciute, European Medical Students Association, Lithuania: How can we address the sex and gender gaps in medical students’ knowledge?
Dr. Katrín Fjeldsted, CPME: How can we address the sex and gender gaps in medical professional knowledge through continuing medical education?
Prof. Dr. Harm Peters, Association of Medical Schools in Europe (AMSE), Germany: Standard setting and quality assurance
Dr. Janusz Janczukowicz, AMEE—International Association For Medical Education, UK: How can we integrate and coordinate sex and gender into medical education cross-nationally across Europe?
16.40-17.30 Towards a European S&G Roadmap: Recommendations
Prof. Dr. Ineke Klinge Univ of Maastricht
Dr. Petra Verdonk, VU University Medical Centre
Dr. Katrín Fjeldsted, CPME
Ms. Peggy Maguire, EIWH
European Gender Medicine Network (EUGenMed)
Grant agreement number 602050
A project funded by the European Commission
Directorate-General for Research & Innovation